Pharmacokinetics of multiple-dose administration of eltenac in horses

American Journal of Veterinary Research

Volumn 59, Issue 11, 1998, Pages 1447-1450

  Dyke, T M ^a,c   Sams, R A ^a   Thompson, K G ^b   Ashcraft, S M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Natl Registration Auth Agric V   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ELTENAC; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DOSE TIME EFFECT RELATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; FEMALE; HORSE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; STEADY STATE;

ANILINE COMPOUNDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; HORSES; INJECTIONS, INTRAVENOUS; THIOPHENES;

EID: 0031771778     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Hamm D, Turchi P, Johnson JC, et al. Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis. Am J Vet Res 1997;58:298-302.
2. Prugner W, Huber R, Luhmann R. Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects. J Vet Pharmacol Ther 1991;14:193-199.